Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors

Antiviral Research

Volumn 54, Issue 3, 2002, Pages 143-147

  Boivin, Guy ^a,b   Goyette, Nathalie ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Influenza A; Influenza B; Inhibitors; Virus

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; PERAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR;

ARTICLE; CANADA; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG POTENCY; DRUG SENSITIVITY; IC 50; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS STRAIN;

ACETAMIDES; CANADA; CHEMILUMINESCENT MEASUREMENTS; CYCLOPENTANES; DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; FLUOROMETRY; GUANIDINES; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; INHIBITORY CONCENTRATION 50; NEURAMINIDASE; OSELTAMIVIR; PYRANS; SIALIC ACIDS; ZANAMIVIR;

EID: 0036224125     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(01)00219-4     Document Type: Article

References (15)

1. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir
2. Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies
3. Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults
4. Evaluation of a rapid optical immunoassay for influenza viruses (FLU OIA Test) in comparison with cell culture and reverse transcription-PCR
5. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir
6. Prevention and treatment of influenza
7. Activity of the neuraminidase inhibitor RWJ-270201 (BCX-1812) against influenza A and B viruses in the neuraminidase inhibition assays
8. Influenza virus neuraminidase inhibitors
9. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections
10. Inhaled zanamivir for the prevention of influenza in families
11. Resistance of influenza viruses to neuraminidase inhibitors - A review
12. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
13. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201
14. Cyclopentane neuraminidase inhibitors with potent in vitro anti- influenza virus activities
15. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial